Plus Therapeutics Inc (PSTV)
1.90
+0.10
(+5.56%)
USD |
NASDAQ |
May 06, 14:14
Plus Therapeutics Enterprise Value: 3.260M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 3.260M |
| May 02, 2024 | 3.260M |
| May 01, 2024 | 2.912M |
| April 30, 2024 | 3.001M |
| April 29, 2024 | 2.651M |
| April 26, 2024 | 2.781M |
| April 25, 2024 | 2.672M |
| April 24, 2024 | 2.389M |
| April 23, 2024 | 2.52M |
| April 22, 2024 | 2.651M |
| April 19, 2024 | 2.52M |
| April 18, 2024 | 2.787M |
| April 17, 2024 | 3.108M |
| April 16, 2024 | 3.043M |
| April 15, 2024 | 2.999M |
| April 12, 2024 | 3.522M |
| April 11, 2024 | 3.565M |
| April 10, 2024 | 3.609M |
| April 09, 2024 | 3.434M |
| April 08, 2024 | 3.652M |
| April 05, 2024 | 3.609M |
| April 04, 2024 | 3.761M |
| April 03, 2024 | 3.652M |
| April 02, 2024 | 3.565M |
| April 01, 2024 | 3.260M |
| Date | Value |
|---|---|
| March 28, 2024 | 3.282M |
| March 27, 2024 | 3.478M |
| March 26, 2024 | 3.522M |
| March 25, 2024 | 3.783M |
| March 22, 2024 | 3.565M |
| March 21, 2024 | 3.347M |
| March 20, 2024 | 3.522M |
| March 19, 2024 | 3.478M |
| March 18, 2024 | 2.912M |
| March 15, 2024 | 2.956M |
| March 14, 2024 | 2.564M |
| March 13, 2024 | 3.130M |
| March 12, 2024 | 3.130M |
| March 11, 2024 | 2.433M |
| March 08, 2024 | 2.781M |
| March 07, 2024 | 2.956M |
| March 06, 2024 | 3.848M |
| March 05, 2024 | 4.915M |
| March 04, 2024 | 4.697M |
| March 01, 2024 | 4.088M |
| February 29, 2024 | 3.870M |
| February 28, 2024 | 3.826M |
| February 27, 2024 | 3.870M |
| February 26, 2024 | 3.391M |
| February 23, 2024 | 3.777M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-4.711M
Minimum
May 11 2022
26.22M
Maximum
Feb 24 2021
6.198M
Average
3.859M
Median
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 1.055B |
| Retractable Technologies Inc | -12.89M |
| Xtant Medical Holdings Inc | 126.76M |
| Asensus Surgical Inc | 44.48M |
| Catheter Precision Inc | 0.8601M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.81M |
| Total Expenses (Quarterly) | 3.86M |
| EPS Diluted (Quarterly) | -0.70 |
| Earnings Yield | -231.1% |
| Normalized Earnings Yield | -164.57 |